Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Gross Profit (2016 - 2026)

Champions Oncology (CSBR) has 16 years of Gross Profit data on record, last reported at $7.8 million in Q4 2025.

  • For Q4 2025, Gross Profit fell 33.78% year-over-year to $7.8 million; the TTM value through Oct 2025 reached $39.1 million, up 29.23%, while the annual FY2025 figure was $49.4 million, 138.02% up from the prior year.
  • Gross Profit reached $7.8 million in Q4 2025 per CSBR's latest filing, up from $6.0 million in the prior quarter.
  • Across five years, Gross Profit topped out at $14.9 million in Q2 2025 and bottomed at -$6.8 million in Q2 2021.
  • Average Gross Profit over 5 years is $7.4 million, with a median of $7.3 million recorded in 2022.
  • Peak YoY movement for Gross Profit: plummeted 189.21% in 2021, then skyrocketed 460.34% in 2025.
  • A 5-year view of Gross Profit shows it stood at $6.2 million in 2021, then grew by 10.7% to $6.8 million in 2022, then skyrocketed by 43.0% to $9.8 million in 2023, then increased by 20.04% to $11.7 million in 2024, then plummeted by 33.78% to $7.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Gross Profit were $7.8 million in Q4 2025, $6.0 million in Q3 2025, and $14.9 million in Q2 2025.